CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 36 filers reported holding CORREVIO PHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $7,000 | -12.5% | 19,000 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | -77.8% | 19,000 | 0.0% | 0.00% | – |
| Q3 2019 | $36,000 | -10.0% | 19,000 | 0.0% | 0.00% | – |
| Q2 2019 | $40,000 | -31.0% | 19,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $58,000 | +31.8% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $44,000 | -42.1% | 19,000 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $76,000 | – | 19,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|